Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Summary
- In clinical trials of antiretroviral-naive patients, the proportion of patients achieving undetectable HIV-1 RNA was approximately 90%[Sax 2017]
- Most patients will likely continue treatment with the same antiretroviral regimen for many years
- For some patients there are often important, nonvirologic reasons to modify their antiretroviral regimen, such as drug intolerance or the need to simplify the regimen
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Switch Strategies